Specipime 2.250gm Injection
Marketer
Fusion Healthcare Pvt Ltd
Salt Composition
Cefepime (2000mg) + Tazobactum (250mg)
Overview Specipime 2.250gm Injection
Cephalosporin duo, a 2.25g injectable antibiotic blend, combats diverse bacterial infections by inhibiting microbial proliferation. Administration requires strict medical oversight; adhere diligently to the prescribed dosage schedule, completing the entire course regardless of symptom improvement. Potential side effects include gastrointestinal upset (nausea, vomiting, diarrhea), skin reactions (rashes), and localized injection site inflammation (redness, swelling, pain), typically resolving spontaneously. Severe side effects or allergic responses (rash, itching, swelling, respiratory distress) necessitate immediate medical attention. Prior to treatment, disclose all existing medications and health conditions to your physician; this includes informing them of pregnancy or breastfeeding. Concurrent alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing, driving should be avoided if drowsiness or dizziness occur.
Uses of Specipime 2.250gm Injection
Infections caused by bacteria
Major Benefits of Specipime 2.250gm Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is not advised.
Common Side effects of Specipime 2.250gm Injection:
- Diarrhea
- Increased white blood cell count (eosinophils)
- Injection site phlebitis
- Skin rash
- Increased liver enzymes
- Positive Coombs test
How to use Specipime 2.250gm Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Specipime 2.250gm Injection works:
Specipime 2.250gm Injection unites Cefepime, an antibiotic, with Tazobactum, a beta-lactamase inhibitor. Cefepime's mechanism involves disrupting bacterial cell wall synthesis, a crucial process for bacterial survival. Tazobactum counteracts bacterial enzymes that would otherwise neutralize Cefepime, thereby broadening Specipime's antibacterial effectiveness and mitigating resistance.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when combining Specipime 2.250gm Injection and alcohol. Seek medical advice before doing so.
PregnancySAFE IF PRESCRIBED
The injectable formulation of Specipime (2.250gm) is usually deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no harmful consequences to the fetus; nevertheless, clinical data from human trials remain scarce.
Breast feedingSAFE IF PRESCRIBED
Administration of Specipime 2.250gm Injection is considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer into breast milk, posing no appreciable risk to the infant.
DrivingUNSAFE
Following administration of Specipime 2.250gm Injection, temporary visual blurring may occur. Refrain from operating a vehicle until your vision returns to normal.
KidneyCAUTION
Caution is advised when administering Specipime 2.250gm Injection to individuals with impaired renal function. Dosage modification of Specipime 2.250gm Injection might be necessary. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Specipime 2.250gm Injection in patients with liver impairment is likely safe. Existing evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Specipime 2.250gm Injection :
Omitting a dose of Specipime 2.250gm Injection necessitates contacting your physician.
Facts to Know About Specipime 2.250gm Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
3,018 People bought this recently